MedPath

The Post-operative Effect on Formation of Oedema After Total Knee Arthroplasty With or Without the Use of a Nerve Stimulator (the gekoTM Device)

Not Applicable
Conditions
Rehabilitation
Osteoarthritis, Knee
Joint Diseases
Edema Leg
Interventions
Device: gekoTM
Registration Number
NCT05042492
Lead Sponsor
moveUP bv
Brief Summary

This study will investigate whether the recovery of muscle function of total knee arthroplasty is accelerated with the use of the gekoTM device along with its effect on reducing symptoms such as oedema and inhibition of the muscle function.

Detailed Description

This study will investigate total knee arthroplasty patients:

* One group gets standard of care (i.e. performing exercises \& guidance by a physiotherapist via a CE-marked mobile application, called moveUP)

* Second group gets standard of care + GekoTM device (i.e. non-invasive neuromuscular electrostimulation applied at the peroneal nerve for 10 days after the operation date.)

The primary objective of the study is to assess the post-operative effect of gekoTM on formation of oedema (measured by perometer).

The effect of the gekoTM device on the muscle function \& the overall recovery will be also investigated.

To collect parameters, the patient will be asked to complete questionnaires, including the following patient reported outcomes (PROMs): Knee Injury and Osteoarthritis Outcome Score (KOOS), Knee Society Score (KSS), Euroqol Health questionnaire EQ5D, Forgotten Joint Score (FJS), Oxford Knee Score (OKS).

The collection of the PROMs will give an indication on outcome and overal recovery in the 2 groups.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Primary TKA planned for degenerative OA
  • Subjects must be discharged to home environment and be able to independently perform the activities of daily life
  • Obtain a written informed consent
Exclusion Criteria
  • TED stockings, Dauerbinde, other compressive bandages
  • Mechanical foot pump
  • Cooling device type 'Game Ready'
  • Posttraumatic OA of the knee
  • History of DVT / Flebitis / Pulmonary embolism
  • Surgical treatment of venous insufficiency <1y prior to TKA surgery
  • Neurological deficit of lower limbs
  • Current sciatic irradiating pain in lower limbs
  • History of lumbar fusion
  • Knee Arthroscopy of the involved limb <6m prior to TKA surgery
  • Any per-operative complication related to the TKA procedure (bleeding, fracture, vascular injury, cardiac complication, pulmonary complication)
  • In case of a release during the TKA procedure
  • Any per-operative (e.g. epidural catheter, urethral catheter, intra articular catheter) or post-operative procedure that might interfere with the rehabilitation during and after hospitalization
  • Any scheduled surgery in the 3 months following the reference surgery;
  • Any significant medical condition (e.g. Parkinson's disease, multiple sclerosis, cerebral vascular accident) that might interfere with the rehabilitation
  • Any significant psychiatric disorders, active alcohol/drug abuse
  • Subject is either pregnant or interested in becoming pregnant during the duration of the study
  • Subjects who are currently involved in any investigational drug or device study or have been enrolled in such study within the last 3 months

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group 2: SC (moveUP) with 10 days of gekogekoTMIn group 2: Next to SC (moveUP), the application of a single gekoTM device is used on the operated leg after surgery (day 0). This device will be worn for 24 hours and at least 8 hours from day 1 until day 10.
Primary Outcome Measures
NameTimeMethod
The primary objective of the study is to assess the post-operative effect of gekoTM on formation of oedema following Total Knee Arthroplasty (TKA)until end of rehabilitation (+- 3 months after TKA operation)

This is measured by the use of a perometer. For each patient, change in limb volume shall be calculated as a percentage of original limb volume.

Shapiro-Wilk test shall be used to test whether there is a significant (p\<0.05) departure from normal distribution in either group.

Secondary Outcome Measures
NameTimeMethod
Incidence of Device Deficiencyduring 10 days after TKA operation

Any inadequacy in the identity, quality, durability, reliability, safety or performance of an investigational device, including malfunction, use errors or inadequacy in information supplied by the manufacturer.(MDR Article 2(59))

Sleep quality2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

the wearable measures accelerations during 23h-8h and gives an assumption quality of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up).

Number of days of crutches useuntil end of rehabilitation (+- 3 months after TKA operation)
Oedema measurements - photographic evaluationuntil end of rehabilitation (+- 3 months after TKA operation)

picture of both knees (moveUP): Patients need to make a picture of both knees, using the photo camera on their smartphone to see the swelling of the operated leg compared to the non-operated leg and to evaluate the swelling of the operated leg.

This blind assessment of pictures is performed by a physical therapist.

Pain level2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

Visual analogue scale (VAS), a 0-100 scale with 100 score = the worst pain the patient can feel and 0 = the patient feels no pain

Number of days of NSAID intake2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

NSAID intake stop is defined as no NSAID consumption for 3 consecutive days with no new 3 day-period of NSAID intake.

Recovery of physical activity (PA)2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

number of weeks until post-operative PA level is similar to pre-operative PA level, meaning there is no significant difference between mean post-operative step count (calculated on each post-operative week) and mean pre-operative step count (calculated on 7 days before surgery).

Incidence of Adverse Eventsuntil end of rehabilitation (+- 3 months after TKA operation)

Any untoward medical occurrence, unintended disease or injury or any untoward clinical signs, including an abnormal laboratory finding, in subjects, users or other persons, in the context of a clinical investigation, whether or not related to the investigational device.

(MDR Article 2(57)). The total number adverse events and the total number (%) of patients that had at least 1 adverse event will be stated.

Oedema measurements - subjective slideruntil end of rehabilitation (+- 3 months after TKA operation)

Temperature/swelling: Identical subjective slider as daily evaluated by the patient itself presenting the result as a Visual Analog Scale score, minimum 0 (no swelling) maximum 100 (Very swollen)

Patient Reported Outcome Measures (PROM's)2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

The PROMS's measured:

- FJS: Forgotten Joint score. 12-item mutiple choice score. Total score on 100 (%), lower scores being indicative of worse knee conditions and higher scores being indicative of better knee conditions.

Dosage Painkiller intake2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Dosage NSAID intake2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)
Resume driving a caruntil end of rehabilitation (+- 3 months after TKA operation)

Number of days post-operative

Number of days of Painkiller intake2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

PK intake stop is defined as no PK consumption for 3 consecutive days with no new 3 day-period of PK intake.

Sleep duration2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

the wearable measures accelerations during 23h-8h and gives an assumption duration of sleep during the night. The assumption of amount of sleep is based on: very little registration (deep sleep), little movements (light sleep), a lot of movements (waking up).

Satisfaction and feedback on the geko device (only for patients using the geko)during 10 days after TKA operation

Including:

* Ease of use

* Required level of stimulation (1 to 11)

* Adherence to the geko use: daily collection of number of hours worn during the 10 days the geko device is used

Overall Net Promotor Score (NPS) of the rehabilitation in general2 weeks pre-operative until end of rehabilitation (+- 3 months after TKA operation)

NPS = How likely would you recommend the rehabilitation to your friends or family?". Visual analogue scale (VAS), a 0-100 scale with 100 score = very likely and 0 = not likely

Trial Locations

Locations (1)

AZ maria middelares

🇧🇪

Ghent, East-Flanders, Belgium

© Copyright 2025. All Rights Reserved by MedPath